Nephrology Dialysis Transplantation, Vol 12, Issue 5 981-983, Copyright © 1997 by Oxford University Press
Y Anderson, N Curtis, J Hobbs, C Thompson, C Winearls, G Radda, K Clarke and P Altmann
Background. As abnormally high serum
D-lactate levels may cause nephrological impairment,
we determined whether patients undergoing continuous ambulatory peritoneal
dialysis (CAPD) with lactate-containing fluids have increased serum
D-lactate concentrations.
Methods. D- and
L-lactate concentrations were determined in
peritoneal dialysis fluids and in serum from control subjects
(n = 10), haemodialysis patients
(n = 10), and CAPD patients (n =
30) before and after 1 h of dialysis. Results. We
found the median D-lactate concentration in Dianeal
CAPD fluid to be 26 mM (range 19-27), whereas it was less than 0.5 mM in
DPCA2 fluid. Control, haemodialysis, and CAPD (DPCA2) patient median serum
D-lactate concentrations were below 0.07 mM.
However, CAPD (Dianeal)_patient serum D-lactate
concentrations were 4-fold higher than controls (P
<0.0001), at 0.28 mM, an hour after instillation of
D-lactate-containing fluid. Three patients, whose
serum D-lactate averaged 0.59 mM, were found to have
D-lactate concentrations at 0.22 mM after overnight
cessation of dialysis. Conclusion. We conclude that
CAPD with D-lactate-containing fluids raises serum
D-lactate to abnormal levels.
Keywords: Continuous ambulatory peritoneal dialysis
(CAPD); D-lactate; haemodialysis;
D-lactate; renal failure
ORIGINAL ARTICLES
High serum D-lactate in patients on continuous ambulatory peritoneal dialysis
Department of Biochemistry, University of Oxford, Oxford, UK; Oxford Renal Unit, The Churchill Hospital, Headington, Oxford, UK; Correspondence to YS Anderson, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK
![]()
CiteULike
Connotea
Del.icio.us What's this?